179 related articles for article (PubMed ID: 4740517)
1. Haloprogin for tinea.
Med Lett Drugs Ther; 1973 Aug; 15(17):69-70. PubMed ID: 4740517
[No Abstract] [Full Text] [Related]
2. Drugs for athlete's foot and tinea cruris.
Med Lett Drugs Ther; 1976 Nov; 18(24):101-2. PubMed ID: 1036605
[No Abstract] [Full Text] [Related]
3. Haloprogin therapy for dermatophyte infections.
Katz R; Cahn B
Arch Dermatol; 1972 Dec; 106(6):837-8. PubMed ID: 4565228
[No Abstract] [Full Text] [Related]
4. [Epidermophytoses and Candida mycoses. Treatment and prevention of recurrence].
Meinhof W
Fortschr Med; 1974 Jun; 92(16):673-6. PubMed ID: 4835997
[No Abstract] [Full Text] [Related]
5. Clinical efficacy studies of haloprogin, a new topical antimicrobial agent.
Hermann HW
Arch Dermatol; 1972 Dec; 106(6):839-42. PubMed ID: 4565229
[No Abstract] [Full Text] [Related]
6. Current treatment of dermatophytoses.
Hay RJ
Acta Derm Venereol Suppl (Stockh); 1986; 121():117-23. PubMed ID: 2940791
[TBL] [Abstract][Full Text] [Related]
7. A controlled study of haloprogin and tolnaftate in tinea pedis.
Carter VH
Curr Ther Res Clin Exp; 1972 Jun; 14(6):307-10. PubMed ID: 4625803
[No Abstract] [Full Text] [Related]
8. Superficial mycoses. Therapeutic agents and clinical applications.
Griffith ML; Flowers FP; Araujo OE
Postgrad Med; 1986 Jan; 79(1):151-6, 161. PubMed ID: 3753622
[No Abstract] [Full Text] [Related]
9. Clinical evaluation of haloprogin.
Hermann HW
Toxicol Appl Pharmacol; 1972 Dec; 23(4):598-605. PubMed ID: 4264777
[No Abstract] [Full Text] [Related]
10. Topical griseofulvin in dermatophytoses.
Montes LF; Nimni M
Skinmed; 2011; 9(2):134-5. PubMed ID: 21548526
[No Abstract] [Full Text] [Related]
11. [Clinical experience with 0.5% jaritin ointment and comparison of its effectiveness and tolerance with 1% haloprogin ointment (author's transl)].
Klima J
Cesk Dermatol; 1977 Oct; 52(5):319-23. PubMed ID: 146569
[No Abstract] [Full Text] [Related]
12. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum.
Van Hecke E; Van Cutsem J
Mycoses; 1988 Dec; 31(12):641-9. PubMed ID: 2852776
[No Abstract] [Full Text] [Related]
13. [Antifungal agents].
Bossa R; Galatulas I
Clin Ter; 1981 Oct; 99(1):73-89. PubMed ID: 6458445
[No Abstract] [Full Text] [Related]
14. Evaluation of the effectiveness of griseofulvin, tolnaftate, and placebo in the topical therapy of superficial dermatophytoses.
Zarowny DP; Rogers RS; Tindall JP
J Invest Dermatol; 1975 Apr; 64(4):268-72. PubMed ID: 1090684
[No Abstract] [Full Text] [Related]
15. [Local treatment of dermatomycoses with tolnaftate].
Schmid AH
Med Klin; 1966 Aug; 61(34):1338 passim. PubMed ID: 5995197
[No Abstract] [Full Text] [Related]
16. Dermatophyte infections.
Clayton YM
Postgrad Med J; 1979 Sep; 55(647):605-7. PubMed ID: 392476
[TBL] [Abstract][Full Text] [Related]
17. Griseofulvin in the treatment of dermatomycoses and onychomycoses produced by dermatophytes of the Trichophyton group.
Kubec K
Mycopathol Mycol Appl; 1968 Jan; 34(1):90-3. PubMed ID: 4231313
[No Abstract] [Full Text] [Related]
18. Specific drugs for superficial fungus infections.
Lorek M; Maguire H
Am Fam Physician; 1980 Feb; 21(2):164-5. PubMed ID: 6892538
[No Abstract] [Full Text] [Related]
19. New topical agents for dermatophytosis.
Smith EB
Cutis; 1976 Jan; 17(1):54-8. PubMed ID: 1037098
[TBL] [Abstract][Full Text] [Related]
20. Miconazole--a new topical antifungal drug.
Med Lett Drugs Ther; 1974 Nov; 16(24):97-8. PubMed ID: 4431382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
